デフォルト表紙
市場調査レポート
商品コード
1338906

ビタミンD療法市場、シェア、規模、動向、産業分析レポート:投与経路別、年齢層別、購入パターン別、用途別、地域別、セグメント別予測、2023年~2032年

Vitamin D Therapy Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral); By Age Group; By Purchase Pattern; By Application; By Region; Segment Forecast, 2023 - 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ビタミンD療法市場、シェア、規模、動向、産業分析レポート:投与経路別、年齢層別、購入パターン別、用途別、地域別、セグメント別予測、2023年~2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、ビタミンD療法の世界市場規模は2032年までに80億7,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界保健機関(WHO)によると、世界中で推定10億人がビタミンD不足または欠乏症を抱えています。このことは、ビタミンD療法の市場が大きく成長していることを示しています。インド各地で実施された複数の調査から、あらゆる年齢層でビタミンD欠乏症が広く発生していることが明らかになっています。推定によると、ビタミンD欠乏症の有病率は、新生児と授乳人口(0~6ヵ月)で62.7%、6~60ヵ月児で46.8%、5~20歳児で37.8~97.5%です。包括的なレビューによると、5歳から20歳の子供の37.8%から97.5%がビタミンD欠乏症です。このことは、市場成長のための幅広い機会を生み出すと思われます。

世界中の多くの人々が、十分なビタミンDを摂取できない生活様式や食習慣を採用しています。例えば、日光をあまり浴びない都市部に住む人々や、制限的な食生活を送る人々は、ビタミンD不足のリスクにさらされている可能性があります。そのため、こうしたビタミンD不足に対処するためのビタミンDサプリメントや治療薬の需要が高まっています。世界銀行によると、現在、世界人口の50%以上が都市部に居住しています。都市部に住む人の数は、2045年までに2倍以上の60億人に達すると思われます。このことは、市場の成長と需要をさらに促進すると思われます。

ビタミンD療法市場レポートハイライト

経口セグメントは、利便性、有効性、汎用性、入手可能性、費用対効果などの利点により、より高い成長が見込まれる

高齢者向けセグメントは、欠乏症リスクの増加、高齢化人口の増加、慢性疾患の罹患率の増加により高い成長率を占める

処方薬セグメントは、処方薬に対する患者の嗜好、特許保護、医療従事者の処方習慣により、より高い成長が見込まれます。

骨粗鬆症分野は、世界の骨粗鬆症の有病率の増加と、骨の健康維持におけるビタミンDの重要性に対する認識の高まりにより、著しい成長率が予測されます。

アジア太平洋地域は、ビタミンD欠乏症の罹患率の高さ、政府の取り組み、ライフスタイルにより、著しい成長率が見込まれています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のビタミンD治療市場に関する洞察

  • ビタミンD療法- 業界スナップショット
  • ビタミンD療法市場力学
    • 促進要因と機会
      • 経口薬の需要の高まり
      • 小売薬局の需要の増加
    • 抑制要因と課題
      • 熟練した専門家の不足
  • PESTLE分析
  • ビタミンD療法業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のビタミンD治療市場、投与経路別

  • 主な調査結果
  • イントロダクション
  • オーラル
  • 非経口

第6章 世界のビタミンD治療市場、用途別

  • 主な調査結果
  • イントロダクション
  • 骨粗鬆症
  • くる病
  • 皮膚疾患
  • 筋力低下
  • 自己免疫疾患

第7章 世界のビタミンD治療市場、年齢層別

  • 主な調査結果
  • イントロダクション
  • 子供たち
  • 大人
  • シニア成人

第8章 世界のビタミンD治療市場、購入パターン別

  • 主な調査結果
  • イントロダクション
  • 一般用医薬品
  • 処方薬

第9章 世界のビタミンD療法市場、地域別

  • 主な調査結果
  • イントロダクション
    • ビタミンD療法市場評価、地域別、2019-2032年
  • ビタミンD療法市場-北米
    • 北米:ビタミンD療法市場、投与経路別、2019~2032年
    • 北米:ビタミンD療法市場、購入パターン別、2019年~2032年
    • 北米:ビタミンD治療市場、用途別、2019~2032年
    • 北米:ビタミンD療法市場、年齢層別、2019~2032年
    • ビタミンD療法市場-米国
    • ビタミンD療法市場- カナダ
  • ビタミンD療法市場- 欧州
    • 欧州:ビタミンD療法市場、投与経路別、2019~2032年
    • 欧州:ビタミンD療法市場、購入パターン別、2019~2032年
    • 欧州:ビタミンD療法市場、用途別、2019年~2032年
    • 欧州:ビタミンD療法市場、年齢層別、2019~2032年
    • ビタミンD療法市場- 英国
    • ビタミンD療法市場- フランス
    • ビタミンD療法市場- ドイツ
    • ビタミンD療法市場- イタリア
    • ビタミンD療法市場- スペイン
    • ビタミンD療法市場- オランダ
    • ビタミンD療法市場- ロシア
  • ビタミンD療法市場- アジア太平洋
    • アジア太平洋:ビタミンD療法市場、投与経路別、2019~2032年
    • アジア太平洋地域:ビタミンD療法市場、購入パターン別、2019~2032年
    • アジア太平洋:ビタミンD治療市場、用途別、2019~2032年
    • アジア太平洋地域:ビタミンD療法市場、年齢層別、2019~2032年
    • ビタミンD療法市場- 中国
    • ビタミンD療法市場- インド
    • ビタミンD療法市場- 日本
    • ビタミンD療法市場- マレーシア
    • ビタミンD療法市場- インドネシア
    • ビタミンD療法市場- 韓国
  • ビタミンD療法市場-中東およびアフリカ
    • 中東およびアフリカ:ビタミンD療法市場、投与経路別、2019~2032年
    • 中東およびアフリカ:ビタミンD療法市場、購入パターン別、2019~2032年
    • 中東およびアフリカ:ビタミンD治療市場、用途別、2019~2032年
    • 中東およびアフリカ:ビタミンD療法市場、年齢層別、2019~2032年
    • ビタミンD療法市場- サウジアラビア
    • ビタミンD療法市場- 南アフリカ
    • ビタミンD療法市場- イスラエル
    • ビタミンD療法市場- アラブ首長国連邦
  • ビタミンD療法市場-ラテンアメリカ
    • ラテンアメリカ:ビタミンD療法市場、投与経路別、2019~2032年
    • ラテンアメリカ:ビタミンD療法市場、購入パターン別、2019~2032年
    • ラテンアメリカ:ビタミンD療法市場、用途別、2019~2032年
    • ラテンアメリカ:ビタミンD療法市場、年齢層別、2019~2032年
    • ビタミンD療法市場- メキシコ
    • ビタミンD療法市場- ブラジル
    • ビタミンD療法市場- アルゼンチン

第10章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • GlaxoSmithKline
  • Pfizer
  • Abbott
  • Sanofi
  • Merck
  • Torrent Pharmaceuticals
  • Novartis International
  • Alkem Laboratories
  • Sun Pharmaceutical
  • Cadila Healthcare
図表

List of Tables

  • Table 1 Global Vitamin D Therapy Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Vitamin D Therapy Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Vitamin D Therapy Market, by Age Group, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Vitamin D Therapy Market, by Purchase Pattern, by Region, 2019-2032 (USD Billion)
  • Table 5 Vitamin D Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 8 North America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 9 North America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 10 U.S.: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 11 U.S.: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 12 U.S.: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 13 U.S.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 14 Canada: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 15 Canada: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 17 Canada: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 18 Europe: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 Europe: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 20 Europe: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 21 Europe: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 22 Germany: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Germany: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 25 Germany: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 26 France: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 27 France: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 28 France: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 29 France: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 30 UK: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 UK: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 32 UK: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 33 UK: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 34 Italy: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 35 Italy: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Italy: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 37 Italy: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 42 Spain: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Spain: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Spain: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 45 Spain: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 46 Russia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 47 Russia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Russia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 49 Russia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 54 China: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 China: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 56 China: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 57 China: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 58 Japan: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 59 Japan: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Japan: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 61 Japan: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 62 India: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 India: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 64 India: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 65 India: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 74 South Korea: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 75 South Korea: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 76 South Korea: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 77 South Korea: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 78 Latin America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Latin America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Latin America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 81 Latin America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 82 Brazil: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Brazil: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Brazil: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 85 Brazil: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 86 Mexico: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 87 Mexico: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 88 Mexico: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 89 Mexico: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 90 Argentina: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 91 Argentina: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Argentina: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 93 Argentina: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 98 UAE: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 99 UAE: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 100 UAE: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 101 UAE: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 106 South Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 107 South Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 108 South Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 109 South Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • Table 110 Israel: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 111 Israel: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 112 Israel: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • Table 113 Israel: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Vitamin D Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Purchase Pattern
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Vitamin D Therapy Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Purchase Pattern
  • Figure 9. Global Vitamin D Therapy Market, by Purchase Pattern, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Vitamin D Therapy Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Age Group
  • Figure 13. Global Vitamin D Therapy Market, by Age Group, 2021 & 2030 (USD Billion)
目次
Product Code: PM3350

The global vitamin D therapy market size is expected to reach USD 8.07 billion by 2032, according to a new study by Polaris Market Research. The report "Vitamin D Therapy Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral); By Age Group; By Purchase Pattern; By Application; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

According to the World Health Organization (WHO), an estimated 1 Bn people across the globe have vitamin D insufficiency or deficiency. This indicates a large and growing market for vitamin D therapies. Several studies conducted across India in various regions have revealed a widespread incidence of vitamin D insufficiency in people of all ages. According to estimates, the prevalence of Vit-D deficiency ranges from 62.7% in newborns and breast-feeding populations (0-6 months) to 46.8% in children aged 6 to 60 months and from 37.8 to 97.5% in kids aged 5 to 20. According to a comprehensive review, between 37.8 and 97.5% of children aged 5 to 20 have vitamin D deficiency. This will create a wide range of opportunities for the growth of the market.

Many people around the world are adopting lifestyles and dietary habits that do not provide sufficient vitamin D. For example, people who live in urban areas with little exposure to sunlight or those who follow restrictive diets may be at risk of vitamin D insufficiency. This has led to increased demand for vitamin D supplements and therapies to address these deficiencies. According to the World Bank, Currently, more than 50% of the world's population resides in cities. The number of people living in urban areas will more than double to 6 billion by 2045. This will further fuel the growth and demand for the market.

Vitamin D Therapy Market Report Highlights

Oral segment is anticipated to witness higher growth due to its advantages such as convenience, effectiveness, versatility, availability, and cost-effectiveness

Senior Adults segment accounted for the higher growth rate owing to the increased risk of deficiency, the growing aging population, and the higher incidence of chronic diseases.

Prescription Drugs segment is expected to have a higher growth due to patient preference for prescription drugs, patent protection, and healthcare provider prescribing habits.

Osteoporosis segment is projected to experience a significant growth rate due to the increasing prevalence of osteoporosis worldwide and growing awareness of the importance of vitamin D in maintaining bone health.

Asia Pacific is expected to grow at a significant growth rate owing to the high incidence of vitamin D deficiency, government initiatives and lifestyle.

The global players include: GSK, Pfizer, Abbott, Sanofi, Merck, Torrent Pharmaceuticals, Novartis International, Alkem Laboratories, Sun Pharmaceutical Industries and Cadila Healthcare.

Polaris Market Research has segmented the Vitamin D Therapy market report based on route of administration, age group, purchase pattern, application and region:

Vitamin D Therapy, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral Route
  • Parenteral Route

Vitamin D Therapy, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

  • Children
  • Adults
  • Senior Adults

Vitamin D Therapy, Purchase Pattern Outlook (Revenue - USD Billion, 2019 - 2032)

  • OTC Drugs
  • Prescription Drugs

Vitamin D Therapy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Osteoporosis
  • Rickets
  • Skin Diseases
  • Muscle Weakness
  • Autoimmune Disorders

Vitamin D Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Vitamin D Therapy Market Insights

  • 4.1. Vitamin D Therapy - Industry Snapshot
  • 4.2. Vitamin D Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand of Oral Drugs
      • 4.2.1.2. Increasing Demand for Retail Pharmacies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of skilled professionals
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Vitamin D Therapy Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Vitamin D Therapy Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
  • 5.3. Oral
    • 5.3.1. Global Vitamin D Therapy Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 5.4. Parenteral
    • 5.4.1. Global Vitamin D Therapy Market, by Parenteral, by Region, 2019-2032 (USD Billion)

6. Global Vitamin D Therapy Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Osteoporosis
    • 6.3.1. Global Vitamin D Therapy Market, by Osteoporosis, by Region, 2019-2032 (USD Billion)
  • 6.4. Rickets
    • 6.4.1. Global Vitamin D Therapy Market, by Rickets, by Region, 2019-2032 (USD Billion)
  • 6.5. Skin Diseases
    • 6.5.1. Global Vitamin D Therapy Market, by Skin Diseases, by Region, 2019-2032 (USD Billion)
  • 6.6. Muscle Weakness
    • 6.6.1. Global Vitamin D Therapy Market, by Muscle Weakness, by Region, 2019-2032 (USD Billion)
  • 6.7. Autoimmune Disorders
    • 6.7.1. Global Vitamin D Therapy Market, by Autoimmune Disorders, by Region, 2019-2032 (USD Billion)

7. Global Vitamin D Therapy Market, by Age Group

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • 7.3. Children
    • 7.3.1. Global Vitamin D Therapy Market, by Children, by Region, 2019-2032 (USD Billion)
  • 7.4. Adults
    • 7.4.1. Global Vitamin D Therapy Market, by Adults, by Region, 2019-2032 (USD Billion)
  • 7.5. Senior Adults
    • 7.5.1. Global Vitamin D Therapy Market, by Senior Adults, by Region, 2019-2032 (USD Billion)

8. Global Vitamin D Therapy Market, by Purchase Pattern

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
  • 8.3. OTC Drugs
    • 8.3.1. Global Vitamin D Therapy Market, by OTC Drugs, by Region, 2019-2032 (USD Billion)
  • 8.4. Prescription Drugs
    • 8.4.1. Global Vitamin D Therapy Market, by Prescription Drugs, by Region, 2019-2032 (USD Billion)

9. Global Vitamin D Therapy Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Vitamin D Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Vitamin D Therapy Market - North America
    • 9.3.1. North America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.2. North America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
    • 9.3.3. North America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
    • 9.3.4. North America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.3.5. Vitamin D Therapy Market - U.S.
      • 9.3.5.1. U.S.: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.3.6. Vitamin D Therapy Market - Canada
      • 9.3.6.1. Canada: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • 9.4. Vitamin D Therapy Market - Europe
    • 9.4.1. Europe: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.5. Vitamin D Therapy Market - UK
      • 9.4.5.1. UK: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.6. Vitamin D Therapy Market - France
      • 9.4.6.1. France: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.7. Vitamin D Therapy Market - Germany
      • 9.4.7.1. Germany: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.8. Vitamin D Therapy Market - Italy
      • 9.4.8.1. Italy: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.9. Vitamin D Therapy Market - Spain
      • 9.4.9.1. Spain: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.10. Vitamin D Therapy Market - Netherlands
      • 9.4.10.1. Netherlands: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.11. Vitamin D Therapy Market - Russia
      • 9.4.11.1. Russia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • 9.5. Vitamin D Therapy Market - Asia Pacific
    • 9.5.1. Asia Pacific: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.5. Vitamin D Therapy Market - China
      • 9.5.5.1. China: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.6. Vitamin D Therapy Market - India
      • 9.5.6.1. India: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.7. Vitamin D Therapy Market - Japan
      • 9.5.7.1. Japan: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.8. Vitamin D Therapy Market - Malaysia
      • 9.5.8.1. Malaysia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.9. Vitamin D Therapy Market - Indonesia
      • 9.5.9.1. Indonesia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.10. Vitamin D Therapy Market - South Korea
      • 9.5.10.1. South Korea: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • 9.6. Vitamin D Therapy Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.5. Vitamin D Therapy Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.6. Vitamin D Therapy Market - South Africa
      • 9.6.6.1. South Africa: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.7. Vitamin D Therapy Market - Israel
      • 9.6.7.1. Israel: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.8. Vitamin D Therapy Market - UAE
      • 9.6.8.1. UAE: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
  • 9.7. Vitamin D Therapy Market - Latin America
    • 9.7.1. Latin America: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.5. Vitamin D Therapy Market - Mexico
      • 9.7.5.1. Mexico: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.6. Vitamin D Therapy Market - Brazil
      • 9.7.6.1. Brazil: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.7. Vitamin D Therapy Market - Argentina
      • 9.7.7.1. Argentina: Vitamin D Therapy Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Vitamin D Therapy Market, by Purchase Pattern, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Vitamin D Therapy Market, by Application, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Vitamin D Therapy Market, by Age Group, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. GlaxoSmithKline
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Pfizer
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Abbott
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Sanofi
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Merck
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Torrent Pharmaceuticals
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Novartis International
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Alkem Laboratories
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Sun Pharmaceutical
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Cadila Healthcare
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development